Home Article Purchase mix will shift when Philips re-enters market, survey finds 

Purchase mix will shift when Philips re-enters market, survey finds 

Purchase mix will shift when Philips re-enters market, survey finds 

Vendors

Default Author Head Shot

By HME News Staff

Updated 9:31 AM CDT, Mon September 18, 2023

NEW YORK – ResMed will likely lose CPAP device market share when Philips re-enters the market, according to the 3Q23 HME Sleep and Oxygen Survey from Needham.  

Respondents to the survey indicated that if Philips re-entered the market and had unconstrained supply, they would return to purchasing 26% of their pre-recall CPAP device volume from Philips, though that’s down from 32% in a prior survey. 

Additionally, when Philips re-enters the market, 8% of respondents expect to decrease ResMed purchases and increase Philips purchases, 23% expect to decrease non-ResMed purchases and increase Philips purchases, and 15% expect to decrease both ResMed and non-ResMed purchases and increase Philips purchases. The remaining 54% expect to maintain their current purchase mix. 

Needham expects Philips to re-enter the market in the second half of 2023 or the first half of 2024, depending on the outcome of a consent decree. 

Other highlights from the survey: 

  • CPAP device availability from ResMed and its competitors was relatively stable compared to a prior survey. 

  • ResMed looks likely to lose both CPAP device and mask market share in the next 12 months. 

  • Price increases for CPAP devices and masks are moderating. 

  • Respondents saw low, single-digit growth in sleep patient volume in the last 12 months, likely due to improved CPAP device supply. 

Comments

To comment on this post, please log in to your account or set up an account now.